Trisha Shetty (Editor)

Astex

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Industry  Pharmaceutical
Revenue  not available
Founder  Joseph Rubinfeld
Type  Subsidiary
Products  oncology treatments
Headquarters  Cambridge, United Kingdom
Founded  1999
Astex lifesciencesinstinctifcomtimthumbphpw218ampzc
Key people  Harren Jhoti (CEO) Martin Buckland (CBO)
Website  www.astex-therapeutics.com

Astex pharmaceuticals small molecule therapeutics with focus on oncology hematology


Astex Therapeutics was a biotechnology company focused on the discovery and development of drugs in oncology and other areas. Astex was founded in 1999 by Sir Tom Blundell, Chris Abell & Harren Jhoti, and is located in Cambridge, England.

Contents

The company's research efforts focus on utilization of a proprietary "drug discovery engine" dubbed Pyramid. Astex has also solved the structure of two key cytochrome P450 isoenzymes involved in drug metabolism, 2C9 & 3A4, which the company hopes will help in optimizing the pharmacokinetic properties and safety of their lead compounds.

Astex Therapeutic's first drug candidate, a cell cycle inhibitor, entered Phase I clinical trials in 2005. Since that time they have created eight drugs that have progressed into the clinical stage of development.

Recent news

In September 2013, Astex was acquired by Otsuka Pharmaceutical for around $900 million.

References

Astex Wikipedia


Similar Topics
I Only Have Eyes for You (film)
You Kiss like a God
Mickey Edelstein
Topics
 
B
i
Link
H2
L